VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BOLT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksBOLTInstitutional Holders

BOLT logoBolt Biotherapeutics, Inc. (BOLT) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership decreased this quarter (-0.95 pp), while top 10 holders maintain a highly concentrated 92.0% of value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
31.0%$2M total value · ▼ 0.95 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
43 / 100Neutral
Institutions & Flow23 holders-1 net flow (+2 / -3)

AI Insights & Key Takeaways

  • Negative Institutional Flow (-1)
  • Renaissance Technologies Llc and Citadel Advisors Llc maintain significant positions
  • Top 10 holders control 92.0% of institutional value
  • No Insider Signal

Top Institutional Holders of BOLT

Ranked by reported Q2 2026 13F market value

Top 10 Holders
92.0%
Top 25 Holders
100.0%

Share of total reported institutional value in BOLT held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1Sofinnova Investments, Inc.138K$530K0.0%7.167%0.03%
2RENAISSANCE TECHNOLOGIES LLC99K$380K+27.7%5.133%0.00%
3

Quarterly Institutional Activity

Filings activity in BOLT during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers2Added To4Trimmed17Exited3
  • NewEdge Advisors, LLC$10K
  • CITIGROUP INC$158

BOLT Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 2026234.2%31.04%0.95 pp$2M7.2%
Q1 202624+14%31.99%+0.54 pp$2M24%
Q4 2025218.7%31.45%9.90 pp$3M22%
Q3 20252312%41.35%5.13 pp$4M17%
Q2 20252616%46.48%1.40 pp$5M30%
Q1 20253121%

How BOLT Compares to Peers

Institutional ownership and quarterly buying activity across the largest Immunology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
LKFTLakefront Biotherapeutics N.V.$2.19B49.6%79-12
YARWYarrow Bioscience Inc$145M1.2%47+2
RKTORocket One Inc.$9M7.9%22+3

BOLT — Frequently Asked Questions

Quick answers to the most common questions about buying BOLT stock.

What percentage of BOLT is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Bolt Biotherapeutics, Inc. stands at 31.0%, held across 23 reporting institutions.

Who is the largest institutional holder of BOLT?

Sofinnova Investments, Inc. is the largest reported institutional holder of BOLT, with approximately 137,721 shares worth $0.00B as of Q2 2026.

Is BOLT a hedge fund favorite?

Yes — 2 widely-followed marquee investors appear among the top 25 institutional holders of BOLT, including RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC.

What is BOLT's Smart Money Score?

Our composite Smart Money Score for BOLT is 43 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought BOLT this quarter?
Vivo Capital, LLC
72K
$279K
0.0%
3.769%
0.03%
4CITADEL ADVISORS LLC57K$219K+462.9%2.961%0.00%
5T3 Companies, LLC38K$146K0.0%1.978%0.16%
6Board of Trustees of The Leland Stanford Junior University36K$139K0.0%1.872%0.03%
7PFIZER INC31K$134K0.0%1.629%0.08%
8Lynx1 Capital Management LP31K$119K0.0%1.603%0.01%
9NANO CAP NEW MILLENNIUM GROWTH FUND L P28K$106K0.0%1.431%0.08%
10GEODE CAPITAL MANAGEMENT, LLC19K$74K-33.6%0.995%0.00%
11Shay Capital LLC15K$59K+3.6%0.803%0.00%
12BlackRock, Inc.10K$37K0.0%0.505%0.00%
13VANGUARD CAPITAL MANAGEMENT LLC7K$27K0.0%0.367%0.00%
14Nan Fung Group Holdings Ltd5K$19K-82.9%0.260%0.01%
15MORGAN STANLEY3K$12K-1.4%0.164%0.00%
16VANGUARD FIDUCIARY TRUST CO3K$12K0.0%0.161%0.00%
17NewEdge Advisors, LLC3K$10K—0.132%0.00%
18Tower Research Capital LLC (TRC)2K$7K+56.5%0.089%0.00%
19UBS Group AG255$982-67.6%0.013%0.00%
20SBI Securities Co., Ltd.130$501+1200.0%0.007%0.00%
21JPMORGAN CHASE & CO42$1650.0%0.002%0.00%
22CITIGROUP INC41$158—0.002%0.00%
23BARCLAYS PLC6$230.0%0.000%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in BOLT — a direct measure of their conviction.

47.88%
0.99 pp
$7M
27%
Q4 202439+18%48.87%0.35 pp$10M18%
Q3 202433—49.22%—$12M—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

2 institutions opened new positions in BOLT during Q2 2026, while 3 fully exited. 4 added to existing positions and 17 trimmed.

How is institutional ownership of BOLT changing?

BOLT institutional ownership fell by 0.95 percentage points quarter-over-quarter, with a net change of -1 holders.

How concentrated is BOLT ownership among the top holders?

The top 10 institutions account for 92.0% of all reported 13F value in BOLT, and the top 25 account for 100.0%.

How does BOLT compare to Immunology Biotech on institutional ownership?

Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.

Where does this BOLT institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

BOLTBolt Biotherapeutics, Inc.
$5.10$10M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership